Index of reports
> All Cases (43)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Megace (Megestrol) all cases. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 43 Next >>
Possible Megace side effects in
Reported by a consumer/non-health professional from Norway on 2012-07-11
Patient:
Reactions: Generalised Erythema, Renal Impairment, Rash
Drug(s) suspected as cause:
Megace
Possible Megace side effects in 81 year old male
Reported by a consumer/non-health professional from United States on 2012-06-21
Patient: 81 year old male, weighing 52.0 kg (114.4 pounds)
Reactions: Confusional State, Balance Disorder
Drug(s) suspected as cause:
Megace
Administration route: Oral
Indication: Weight Decreased
Start date: 2012-04-27
End date: 2012-04-30
Megace
Administration route: Oral
Indication: Decreased Appetite
Start date: 2012-04-27
End date: 2012-04-30
Namenda
Dosage: form: tabs
Administration route: Oral
Indication: Dementia
Start date: 2012-04-27
End date: 2012-04-30
Other drugs received by patient: Nexium; Glucosamine; Flomax; Multi-Vitamins; Asmanex Twisthaler; Exelon; Spiriva
Possible Megace side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-08
Patient: female, weighing 74.8 kg (164.7 pounds)
Reactions: Deep Vein Thrombosis
Drug(s) suspected as cause:
Megace
Dosage: 400, 2x daily, po
Administration route: Oral
Indication: Appetite Disorder
Start date: 2012-05-27
End date: 2012-05-31
Megace
Dosage: 400, 2x daily, po
Administration route: Oral
Indication: Appetite Disorder
Start date: 2012-05-17
End date: 2012-05-20
Possible Megace side effects in 81 year old male
Reported by a consumer/non-health professional from United States on 2012-05-22
Patient: 81 year old male, weighing 52.0 kg (114.4 pounds)
Reactions: Confusional State, Balance Disorder
Drug(s) suspected as cause:
Megace
Indication: Weight Decreased
Start date: 2012-04-27
End date: 2012-04-30
Namenda
Dosage: form: tabs
Administration route: Oral
Indication: Dementia
Start date: 2012-04-27
End date: 2012-04-30
Megace
Indication: Decreased Appetite
Start date: 2012-04-27
End date: 2012-04-30
Other drugs received by patient: Flomax; Spiriva; Nexium; Exelon; Asmanex Twisthaler; Multi-Vitamins; Glucosamine
Possible Megace side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10
Patient: 75 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Vomiting, Nausea, Dehydration, Blood Glucose Increased, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metformin HCL
Start date: 2012-03-07
Decadron
Indication: Premedication
Start date: 2012-02-08
Megace
Administration route: Oral
Indication: Decreased Appetite
Start date: 2012-04-12
Other drugs received by patient: Lovastatin; Insulin; Kytril; Aspirin; Centrum; Vitamin B-12
Possible Megace side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-08
Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)
Reactions: Anaemia, Uterine Leiomyoma, Gastrooesophageal Reflux Disease, Decreased Appetite, Hypokalaemia, Vaginal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metoprolol Tartrate
Dosage: 25 mg (25 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
Axitinib (Axitinib)
Dosage: 10 mg (5 mg, 2 in 1 d), oral; 6 mg (3 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-06-28
Axitinib (Axitinib)
Dosage: 10 mg (5 mg, 2 in 1 d), oral; 6 mg (3 mg, 2 in 1 d), oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-11-30
Carboplatin
Dosage: (670 mg), intravenous; 26.9048 mg (565 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-09-22
End date: 2011-09-22
Carboplatin
Dosage: (670 mg), intravenous; 26.9048 mg (565 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Paclitaxel
Dosage: (300 mg), intravenous; 10.2381 mg (215 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-09-22
End date: 2011-09-22
Paclitaxel
Dosage: (300 mg), intravenous; 10.2381 mg (215 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Prempro
Dosage: 0.625mg/2.5mg (1 in 1 d), oral;
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Celecoxib
Dosage: 200 mg (200 mg, 1 in 1 d), oral; 200 mg (200 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Megace
Dosage: 5 cc (5, 1 in 1 d), oral; 5 cc (5, 1 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
Megace
Dosage: 5 cc (5, 1 in 1 d), oral; 5 cc (5, 1 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-11-28
Other drugs received by patient: Benadryl; MS Contin; Zofran; Wellbutrin
Possible Megace side effects in 79 year old male
Reported by a consumer/non-health professional from Italy on 2012-05-03
Patient: 79 year old male
Reactions: Hyperthyroidism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Megace
Dosage: 160 mg per square meter of body surface/day interr on 31oct2011
Administration route: Oral
Indication: Increased Appetite
Start date: 2011-09-25
Cordarone
Administration route: Oral
Indication: Arrhythmia
Start date: 2011-10-18
End date: 2011-11-10
Other drugs received by patient: Tamsulosin HCL; Allopurinol; Levothyroxine Sodium; Zanedip
Possible Megace side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-30
Patient: female, weighing 65.9 kg (145.0 pounds)
Reactions: Anaemia, Vaginal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 565 mg, every 3 weeks
Start date: 2011-10-20
End date: 2011-10-20
Metoprolol Tartrate
Dosage: 25 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
Celebrex
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Axitinib
Dosage: 5 mg, 2x/day
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-06-28
Axitinib
Dosage: 3 mg, 2x/day, continuously
Administration route: Oral
Start date: 2011-11-30
Paclitaxel
Dosage: 215 mg, every 3 weeks
Start date: 2011-10-20
End date: 2011-10-20
Celebrex
Dosage: 200 mg, 1x/day
Administration route: Oral
Carboplatin
Dosage: 670 mg, unk
Indication: Metastatic Malignant Melanoma
Start date: 2011-09-22
End date: 2011-09-22
Prempro
Dosage: 0.625 mg/2.5 mg, 1x/day
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Paclitaxel
Dosage: 300 mg, unk
Indication: Metastatic Malignant Melanoma
Start date: 2011-09-22
End date: 2011-09-22
Megace
Dosage: 5cc, 1x/day
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
End date: 2011-10-04
Megace
Dosage: 5 cc, 1x/day
Administration route: Oral
Start date: 2011-11-28
Other drugs received by patient: MS Contin; Benadryl; Wellbutrin; Zofran
Possible Megace side effects in 81 year old male
Reported by a consumer/non-health professional from United States on 2012-04-25
Patient: 81 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Weight Decreased, Diarrhoea, Drug Ineffective
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Megace
Dosage: stopped
Plavix
Dosage: prescription#: 6188960
Start date: 2011-10-01
Possible Megace side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-19
Patient: female
Reactions: Overdose, Thrombocytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Dosage: citalopram overdose: 60 mg daily
Administration route: Oral
Indication: Depression
Start date: 2012-01-19
End date: 2012-02-10
Megace
Dosage: 1 df
Administration route: Oral
Indication: Decreased Appetite
Start date: 2012-02-03
End date: 2012-02-05
Megace
Dosage: 3 df
Administration route: Oral
Start date: 2012-02-06
End date: 2012-02-09
Other drugs received by patient: Calcium Gluconate; Pentasa; Vitamin B1 and B6; Bricanyl; Aluminum Hydroxide and Magnesium Trisilicate; Imodium; Decan; Magnesium Sulfate; Ascorbic Acid; Atrovent; Aspirin; Aldalix; Olimel; Cernevit-12; Phocytan; Nexium; Lovenox; Prednisolone; Fluticasone Propionate / Salmeterol; Singulair
Possible Megace side effects in 82 year old female
Reported by a physician from France on 2012-04-11
Patient: 82 year old female
Reactions: Thrombocytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Administration route: Oral
Indication: Depression
Start date: 2012-01-19
End date: 2012-02-10
Megace
Dosage: 1df:1tab 3,4feb12-5feb12,3tabs 6,7feb12-9feb12
Administration route: Oral
Indication: Decreased Appetite
Start date: 2012-02-03
End date: 2012-02-09
Other drugs received by patient: Prednisolone; Imodium; Vitamin B1 TAB; Vitamin B6; Aldalix; Pentasa; Aspirin; Calcium Gluconate; Aluminum Hydroxide and Magnesium Trisilicate; Bricanyl; Cernevit-12; Fluticasone Propionate / Salmeterol; Phocytan; Magnesium Sulfate; Ascorbic Acid; Singulair; Atrovent; Nexium; Lovenox
Possible Megace side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-04
Patient: female
Reactions: Overdose, Thrombocytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Citalopram Hydrobromide
Dosage: citalopram overdose: 60 mg daily
Administration route: Oral
Indication: Depression
Start date: 2012-01-19
End date: 2012-02-10
Megace
Dosage: 1 df
Administration route: Oral
Indication: Decreased Appetite
Start date: 2012-02-03
End date: 2012-02-05
Megace
Dosage: 3 df
Administration route: Oral
Start date: 2012-02-06
End date: 2012-02-09
Other drugs received by patient: Aldalix; Fluticasone Propionate / Salmeterol; Aluminum Hydroxide and Magnesium Trisilicate; Decan; Aspirin; Cernevit-12; Magnesium Sulfate; Bricanyl; Pentasa; Olimel; Vitamin B1 and B6; Singulair; Calcium Gluconate; Ascorbic Acid; Atrovent; Imodium; Nexium; Lovenox; Phocytan; Prednisolone
Possible Megace side effects in 79 year old male
Reported by a consumer/non-health professional from Italy on 2012-04-03
Patient: 79 year old male
Reactions: Hyperthyroidism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Megace
Dosage: 160 mg per square meter of body surface/day interr on 31oct2011
Administration route: Oral
Indication: Increased Appetite
Start date: 2011-09-25
Cordarone
Administration route: Oral
Indication: Arrhythmia
Start date: 2011-10-18
End date: 2011-11-10
Other drugs received by patient: Allopurinol; Zanedip; Levothyroxine Sodium; Tamsulosin HCL
Possible Megace side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29
Patient: 56 year old female, weighing 84.0 kg (184.8 pounds)
Reactions: Anaemia, Vaginal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metoprolol Tartrate
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
End date: 2011-10-12
Prempro
Dosage: 1 df: 0.625mg/2.5mg
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Axitinib
Dosage: from 30nov2011:3mg twice/daily 5mg twicw daily,2 wks on , 1wk off
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-06-28
Megace
Dosage: 1 df: 5cc 5ml/day from 28nov11
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
End date: 2011-10-04
Celebrex
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Carboplatin
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Celebrex
Administration route: Oral
Indication: Menopause
Start date: 2007-01-01
End date: 2011-11-01
Paclitaxel
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Other drugs received by patient: MS Contin; Wellbutrin; Benadryl; Zofran
Possible Megace side effects in 79 year old male
Reported by a consumer/non-health professional from Italy on 2012-03-28
Patient: 79 year old male
Reactions: Hyperthyroidism
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cordarone
Administration route: Oral
Indication: Arrhythmia
Start date: 2011-10-18
End date: 2011-11-10
Megace
Dosage: 160 mg per square meter of body surface/day interr on 31oct2011
Administration route: Oral
Indication: Increased Appetite
Start date: 2011-09-25
Other drugs received by patient: Allopurinol; Tamsulosin HCL; Zanedip; Levothyroxine Sodium
Possible Megace side effects in 66 year old female
Reported by a physician from United States on 2012-03-23
Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)
Reactions: Confusional State, Abdominal Pain, Vomiting, Mental Status Changes, Headache, Cognitive Disorder, Fatigue, Malaise
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lortab
Dosage: every 6 hours as needed (5mg/500mg)
Indication: Pain
Start date: 2009-04-02
End date: 2009-06-29
Megace
Administration route: Oral
Indication: Appetite Disorder
Radiation
Dosage: qd 5 days a week, x 3weeks external beam 2d
Start date: 2009-03-16
End date: 2009-04-06
Colace
Indication: Constipation
Start date: 2009-04-02
End date: 2009-08-28
Study Medication
Dosage: wk1: 5 mg am,wk2: 5 mg am and 5 mg pm,wk3: 10mg am and 5 mg pm,wk4-24:10 mg am and 10 mg pm
Indication: Prophylaxis
Start date: 2009-05-12
End date: 2009-07-07
Ranitidine
Indication: Ulcer
End date: 2009-08-28
Zofran
Dosage: every 6 hours as needed
Administration route: Oral
Indication: Nausea
End date: 2009-08-28
Simvastatin
Indication: Blood Cholesterol
Start date: 2009-02-27
End date: 2009-08-28
Fergon
Administration route: Oral
Indication: Iron Deficiency
Start date: 2009-02-27
End date: 2009-08-28
Sunitinib Malate
Indication: Renal Cancer
Start date: 2009-06-01
End date: 2009-08-28
Pioglitazone HCL
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-06-04
Other drugs received by patient: Artificial Tear; Aspirin; Actonel; Aspirin; Aspirin; Ciprofloxacin Hydrochloride; Extra Strength Tylenol
Possible Megace side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-22
Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)
Reactions: Confusional State, Abdominal Pain, Vomiting, Blood Urea Increased, Nausea, Mental Status Changes, Cognitive Disorder, Headache, Pallor, Malaise, Fatigue, Posterior Reversible Encephalopathy Syndrome, Disturbance in Attention, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ferrous Gluconate (Ferrous Gluconate) Tablet
Dosage: 325 mg, bid, oral
Administration route: Oral
Indication: Iron Deficiency
Start date: 2009-02-27
End date: 2009-08-28
Lortab
Dosage: 1 df every 6 hours as needed
Indication: Analgesic Therapy
Start date: 2009-08-25
End date: 2009-08-28
Lortab
Dosage: 1 df every 6 hours as needed
Indication: Analgesic Therapy
Start date: 2009-04-02
End date: 2009-06-29
Zofran
Dosage: 1 df every 6 hours as needed, oral
Administration route: Oral
Indication: Nausea
End date: 2009-08-28
Uncodeable ^unclassifiable^ (Uncodeable ^unclassifiable^)
Dosage: qd 5 days a week x 3 weeks
Indication: Product Used FOR Unknown Indication
Start date: 2009-03-16
End date: 2009-04-06
Megace
Dosage: 3 df, qd, oral
Administration route: Oral
Indication: Appetite Disorder
Simvastatin
Dosage: 40 mg, bid
Indication: Blood Cholesterol
Start date: 2009-02-27
End date: 2009-08-28
Sunitinib Malate
Dosage: 50 mg, bid
Indication: Renal Cancer
Start date: 2009-06-01
End date: 2009-08-28
Ranitidine
Dosage: 150 mg, bid
Indication: Ulcer
End date: 2009-08-28
Pioglitazone
Dosage: 30 mg, qd, oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-06-04
Uncodeable ^investigational Drug^ (Uncodeable ^investigational Drug^)
Indication: Prophylaxis
Start date: 2009-05-12
End date: 2009-07-07
Colace (Docusate Sodium)
Dosage: 100 mg, bid
Indication: Constipation
Start date: 2009-04-02
End date: 2009-08-28
Other drugs received by patient: Artificial Tears; Aspirin; Actonel
Possible Megace side effects in 66 year old female
Reported by a consumer/non-health professional from United States on 2012-03-19
Patient: 66 year old female, weighing 59.0 kg (129.8 pounds)
Reactions: Abdominal Pain, Malaise, Vomiting, Fatigue, Cognitive Disorder, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fergon
Administration route: Oral
Indication: Iron Deficiency Anaemia
Start date: 2009-02-27
End date: 2009-08-28
Simvastatin
Indication: Blood Cholesterol
Start date: 2009-02-27
End date: 2009-08-28
Megace
Administration route: Oral
Indication: Appetite Disorder
Colace
Indication: Constipation
Start date: 2009-04-02
End date: 2009-08-28
Sunitinib Malate
Dosage: tab
Indication: Renal Cancer
Start date: 2009-06-01
End date: 2009-08-28
Pioglitazone HCL
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-06-04
Ranitidine
Indication: Ulcer
End date: 2009-08-28
Zofran
Dosage: tabs. every 6 hours;tabs 1df= every 6 hrs as needed
Administration route: Oral
Indication: Nausea
End date: 2009-08-28
Lortab
Dosage: every 6 hours;1df=every 6 hrs 25aug09-28aug09 (3 days)
Indication: Analgesic Therapy
Start date: 2009-04-02
End date: 2009-06-28
Other drugs received by patient: Artificial Tears; Ciprofloxacin Hydrochloride; Extra Strength Tylenol; Actonel; Aspirin
Possible Megace side effects in 56 year old female
Reported by a consumer/non-health professional from United States on 2012-03-19
Patient: 56 year old female, weighing 66.0 kg (145.2 pounds)
Reactions: Anaemia, Vaginal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Celebrex
Administration route: Oral
Indication: Menopause
Start date: 1997-01-01
End date: 2011-11-01
Prempro
Dosage: 1 df: 0.625mg/2.5mg
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Paclitaxel
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Axitinib
Dosage: 3mg twice/daily
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-05
Celebrex
Administration route: Oral
Indication: Arthritis
Start date: 1997-01-01
End date: 2011-11-01
Metoprolol Tartrate
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
End date: 2011-10-12
Megace
Dosage: 1 df: 5cc 5ml/day from 28nov11
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
End date: 2011-10-04
Other drugs received by patient: MS Contin; Zofran; Benadryl; Wellbutrin
Possible Megace side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-16
Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)
Reactions: Uterine Leiomyoma, Haemorrhagic Anaemia, Gastrooesophageal Reflux Disease, Hypokalaemia, Vaginal Haemorrhage
Drug(s) suspected as cause:
Megace
Dosage: 5 cc (5,4 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-11-28
Megace
Dosage: 5 cc (5,4 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
Celecoxib
Dosage: 200 mg (200 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Paclitaxel
Dosage: 10.2381 mg (215 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Metoprolol Tartrate
Dosage: 25 mg (25 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
Carboplatin
Dosage: 26.9048 mg (565 mg, 1 in 3 wk), intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Prempro
Dosage: 0.625mg/2.5mg (1 in 1 d), oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Axitinib (Axitinib)
Dosage: 2 dosage forms (1 dosage forms, 2 in 1 d), oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-11-30
Other drugs received by patient: Wellbutrin (Bupropion0; Benadryl; Zofran; MS Contin
Possible Megace side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-08
Patient: female, weighing 83.8 kg (184.3 pounds)
Reactions: Anaemia, Vaginal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Megace
Dosage: 5cc, 1x/day
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
End date: 2011-10-04
Prempro
Dosage: 0.625 mg/2.5 mg, 1x/day
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Axitinib
Dosage: 3 mg, 2x/day,1 df
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-06-28
Paclitaxel
Dosage: 215 mg, every 3 weeks
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Celebrex
Dosage: 200 mg, 1x/day
Administration route: Oral
Axitinib
Dosage: 3 mg, 2x/day, continuously
Administration route: Oral
Start date: 2011-11-30
Megace
Dosage: 5 cc, 1x/day
Administration route: Oral
Start date: 2011-11-28
Metoprolol Tartrate
Dosage: 25 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
End date: 2011-10-12
Carboplatin
Dosage: 565 mg, every 3 weeks
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Celebrex
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Other drugs received by patient: Wellbutrin; Benadryl; Zofran; MS Contin
Possible Megace side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07
Patient: 56 year old female, weighing 83.8 kg (184.3 pounds)
Reactions: Uterine Leiomyoma, Haemorrhagic Anaemia, Gastrooesophageal Reflux Disease, Decreased Appetite, Vaginal Haemorrhage, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Axitinb (Axitinib)
Dosage: 2 dosage forms (1 dosage forms,2 in 1 d),oral ; 6 mg (3 mg,2 in 1 d),oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-06-28
Axitinb (Axitinib)
Dosage: 2 dosage forms (1 dosage forms,2 in 1 d),oral ; 6 mg (3 mg,2 in 1 d),oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-11-30
Carboplatin
Dosage: 26.9048 mg (565 mg,1 in 3 wk),intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Megace
Dosage: 5 cc (5, 4 in 1 d),oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
Metoprolol Tartrate
Dosage: 25 mg (25 mg,1 in 1 d),oral
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
Celecoxib
Dosage: 200 mg (200 mg,1 in 1 d),oral ; 200 mg (200 mg,1 in 1 d),oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Prempro
Dosage: 0.625mg/2.5mg (1 in 1 d),oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Paclitaxel
Dosage: 10.2381 mg (215 mg,1 in 3 wk),intravenous
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Other drugs received by patient: Benadryl; MS Contin; Wellbutrin; Zofran
Possible Megace side effects in 57 year old female
Reported by a consumer/non-health professional from United States on 2012-03-06
Patient: 57 year old female
Reactions: Disease Complication, Weight Decreased, Hepatitis C, Product Taste Abnormal
Adverse event resulted in: death
Drug(s) suspected as cause:
Megace
Possible Megace side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05
Patient: female
Reactions: Abdominal Pain, Fatigue, Vomiting, Malaise, Headache, Cognitive Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Simvastatin
Indication: Blood Cholesterol
Start date: 2009-02-27
End date: 2009-08-28
Fergon
Administration route: Oral
Indication: Iron Deficiency
Start date: 2009-02-27
End date: 2009-08-28
Pioglitazone Hydrochloride
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-06-04
Colace
Indication: Constipation
Start date: 2009-03-02
End date: 2009-08-28
Ranitidine
Indication: Ulcer
End date: 2009-08-28
Lortab
Dosage: 5mg/500mg every 6 hours, as needed
Indication: Analgesic Therapy
Start date: 2009-03-02
End date: 2009-08-28
Zofran
Dosage: every 6 hours, as needed
Administration route: Oral
Indication: Nausea
End date: 2009-08-28
Sunitinib Malate
Indication: Renal Cancer
Start date: 2009-06-01
End date: 2009-08-28
Dutogliptin
Dosage: investigational drug
Indication: Type 2 Diabetes Mellitus
Start date: 2009-03-16
End date: 2009-04-06
Megace
Dosage: daily
Administration route: Oral
Indication: Decreased Appetite
Other drugs received by patient: Actonel; Hypromellose; Cipro; Aspirin; Aspirin; Aspirin
Possible Megace side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02
Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)
Reactions: Abdominal Pain, Confusional State, Vomiting, Blood Urea Increased, Mental Status Changes, Cognitive Disorder, Headache, Malaise, Fatigue
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zofran
Dosage: 1 dosage forms, every 6 hrs, as needed, oral
Administration route: Oral
Indication: Nausea
End date: 2009-08-28
Megace
Dosage: daily, oral
Administration route: Oral
Indication: Decreased Appetite
Fergon
Dosage: 325 mg, 2 in 1 d, oral
Administration route: Oral
Indication: Blood Iron Decreased
Start date: 2009-02-27
End date: 2009-08-28
Dutoglipitin (Investigational Drug)
Indication: Type 2 Diabetes Mellitus
Start date: 2009-03-16
End date: 2009-04-06
Colace (Docusate Sodium)
Dosage: 100 mg, 2 in 1 d
Indication: Constipation
Start date: 2009-04-02
End date: 2009-08-28
Lortab
Dosage: 5 mg/500 mg every 6 hrs, as needed
Indication: Analgesic Therapy
Start date: 2009-04-02
End date: 2009-08-28
Sunitinib Malate
Dosage: 100 mg, 2 in 1 d
Indication: Renal Cancer
Start date: 2009-06-01
End date: 2009-08-28
Pioglitazone Hydrochloride
Dosage: 30 mg, oral
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-06-04
Ranitidine Hydrochloride
Dosage: 300 mg
Indication: Ulcer
End date: 2009-08-28
Simvastatin
Dosage: 40 mg, 2 in 1 d
Indication: Blood Cholesterol Increased
Start date: 2009-02-27
End date: 2009-08-28
Other drugs received by patient: Artificial Tear (Hypromellose); Cipro; Actonel; Aspirin
Possible Megace side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-02
Patient: female, weighing 83.8 kg (184.3 pounds)
Reactions: Anaemia, Vaginal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 565 mg, every 3 weeks
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Megace
Dosage: 5 cc, 1x/day
Administration route: Oral
Start date: 2011-11-28
Axitinib
Dosage: 3 mg, 2x/day,1 df
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-06-28
Metoprolol Tartrate
Dosage: 25 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
End date: 2011-10-12
Celebrex
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
End date: 2011-11-01
Paclitaxel
Dosage: 215 mg, every 3 weeks
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-20
End date: 2011-10-20
Prempro
Dosage: 0.625 mg/2.5 mg, qd
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Celebrex
Dosage: 200 mg, 1x/day
Administration route: Oral
Megace
Dosage: 5cc, qd
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
End date: 2011-10-04
Other drugs received by patient: Benadryl; Zofran; Wellbutrin; MS Contin
Possible Megace side effects in female
Reported by a physician from United States on 2012-02-27
Patient: female, weighing 59.4 kg (130.7 pounds)
Reactions: Abdominal Pain, Malaise, Vomiting, Fatigue, Cognitive Disorder, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Study Drug
Dosage: unk
Indication: Prophylaxis
Start date: 2009-05-12
End date: 2009-07-07
Lortab
Dosage: 1 df, q6h prn
Indication: Analgesic Therapy
Start date: 2009-04-02
End date: 2009-06-29
Simvastatin
Dosage: 80 mg, daily
Indication: Blood Cholesterol
Start date: 2009-02-27
End date: 2009-08-28
Ranitidine
Dosage: 300 mg, daily
Indication: Ulcer
End date: 2009-08-28
Zofran
Dosage: 1 df, q6h prn
Administration route: Oral
Indication: Nausea
End date: 2009-08-28
Pioglitazone Hydrochloride
Dosage: 30 mg, daily
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-06-04
Fergon
Dosage: 650 mg, daily
Administration route: Oral
Indication: Iron Deficiency
Start date: 2009-02-27
End date: 2009-08-28
Sunitinib Malate
Dosage: 100 mg, daily
Indication: Renal Cancer
Start date: 2009-06-01
End date: 2009-08-28
Colace Capsules
Dosage: 200 mg, daily
Indication: Constipation
Start date: 2009-04-02
End date: 2009-08-28
Lortab
Dosage: 1 df, q6h prn
Start date: 2009-08-25
End date: 2009-08-28
Megace
Dosage: 3 df, daily
Administration route: Oral
Indication: Appetite Disorder
Radiation
Dosage: every day, five days a week for three weeks
Indication: Product Used FOR Unknown Indication
Start date: 2009-03-16
End date: 2009-04-06
Other drugs received by patient: Artificial Tears / 00445101 /; Aspirin; Actonel; Aspirin; Aspirin; Tylenol (Caplet); Cipro
Possible Megace side effects in 56 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-24
Patient: 56 year old female, weighing 65.9 kg (145.0 pounds)
Reactions: Uterine Leiomyoma, Anaemia, Gastrooesophageal Reflux Disease, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Metoprolol Tartrate
Dosage: 25 mg (25 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Hypertension
Start date: 2011-09-16
Axitinib (Axitinib)
Dosage: 2 dosage forms (1 dosage forms, 2 in 1 d), oral
Administration route: Oral
Indication: Metastatic Malignant Melanoma
Start date: 2011-11-30
Celebrix (Celecoxib)
Dosage: 200 mg (200 mg, 1 in 1 d), oral
Administration route: Oral
Indication: Menopause
Start date: 1997-01-01
End date: 2011-11-01
Prempro
Dosage: 0.625 mg/2.5 mg (1 in 1 d), oral
Administration route: Oral
Indication: Arthritis
Start date: 2007-01-01
Carboplatin
Dosage: 26.9048 mg (565 mg, 1 in 3 wk), intravenous
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-20
End date: 2011-10-20
Paclitaxel
Dosage: 10.2381 mg (215 mg, 1 in 3 wk), intravenous
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-20
End date: 2011-10-20
Megace
Dosage: 5 cc (1 in 1 d), oral
Administration route: Oral
Indication: Decreased Appetite
Start date: 2011-09-27
Other drugs received by patient: Benadryl; Wellbutrin; Zofran; MS Contin; Megace; Celebrex
Possible Megace side effects in female
Reported by a physician from United States on 2012-02-23
Patient: female, weighing 59.4 kg (130.7 pounds)
Reactions: Abdominal Pain, Vomiting, Malaise, Fatigue, Headache, Cognitive Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ranitidine
Dosage: 150 mg, 2x/day
Indication: Ulcer
End date: 2009-08-28
Zofran
Dosage: 1 dosage forms, every 6 hrs
Administration route: Oral
Indication: Nausea
End date: 2009-08-28
Lortab
Dosage: 1 dosage forms, every 6 hours
Start date: 2009-08-25
End date: 2009-08-28
Colace
Dosage: 100 mg, 2x/day
Indication: Constipation
Start date: 2009-04-02
End date: 2009-08-28
Fergon
Dosage: 325 mg, 2x/day
Administration route: Oral
Indication: Iron Deficiency
Start date: 2009-02-27
End date: 2009-08-28
Sunitinib Malate
Dosage: 50 mg, 2x/day
Administration route: Oral
Indication: Renal Cancer
Start date: 2009-06-01
End date: 2009-08-28
Megace
Dosage: unk
Administration route: Oral
Indication: Appetite Disorder
Pioglitazone Hydrochloride
Dosage: 30 mg, 1x/day
Administration route: Oral
Indication: Diabetes Mellitus
Start date: 2007-06-04
Lortab
Dosage: 1 dosage forms, every 6 hours
Indication: Analgesic Therapy
Start date: 2009-04-02
End date: 2009-06-29
Simvastatin
Dosage: 40 mg, 2x/day
Administration route: Oral
Indication: Blood Cholesterol
Start date: 2009-02-27
End date: 2009-08-28
Other drugs received by patient: Ciprofloxacin; Actonel; Aspirin; Extra Strength Tylenol; Artificial Tears; Aspirin; Aspirin
Possible Megace side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-22
Patient: female, weighing 59.4 kg (130.7 pounds)
Reactions: Abdominal Pain, Fatigue, Malaise, Vomiting, Headache, Cognitive Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Megace
Administration route: Oral
Colace
Dosage: 100mg twice per day
Zofran
Administration route: Oral
End date: 2009-08-28
Sunitinib Malate
Dosage: 50mg per day
End date: 2009-08-28
Ferrous Gluconate
Dosage: 325mg twice per day
Administration route: Oral
Indication: Iron Deficiency
End date: 2009-08-28
Radiation
Start date: 2009-04-08
Pioglitazone
Dosage: 30mg per day
Lortab
Simvastatin
Dosage: 40mg twice per day
Administration route: Oral
End date: 2009-08-28
Investigational Drug
Ranitidine
Dosage: 150mg twice per day
End date: 2009-08-28
Other drugs received by patient: Acetaminophen; Aspirin; Citrate OF Magnesia; Carvedilol; Tessalon; Actonel; Cipro; Amlodipine
Page 1 Next >>
|